Professional Summary
Professional Overview
Mark Steffen is an accomplished finance and administration executive with over 20 years of experience in the biotechnology and pharmaceutical industries. As the Vice President of Finance and Administration at Mozart Therapeutics, Inc., he oversees all financial operations, accounting, legal, and administrative functions, driving strategic initiatives to support the company's growth and profitability.
Experience Summary
Current Role
As the Vice President of Finance and Administration at Mozart Therapeutics, Inc., Mark is responsible for leading the company's financial strategy, budgeting, and reporting processes. He works closely with the executive team to identify opportunities for cost savings, optimize resource allocation, and ensure financial compliance. Under his leadership, the finance and administration functions have become instrumental in supporting Mozart Therapeutics' clinical development and commercialization efforts.
Career Progression
Prior to his current role, Mark served as the Senior Director of Finance at Mozart Therapeutics, where he played a pivotal role in streamlining financial operations and implementing robust financial controls. Before joining Mozart Therapeutics, he held the position of Chief Financial Officer at Wilmar, where he was instrumental in driving the company's financial and operational transformation. Mark's earlier career includes roles as Director of Finance and Controller at Theraclone Sciences, as well as Accounting Manager at Corixa Corporation.
Academic Background
Mark holds a Bachelor of Business Administration degree in Accounting from the University of Washington, where he graduated with distinction.
Areas of Expertise
- Financial planning and analysis
- Budgeting and forecasting
- Financial reporting and compliance
- Accounting and internal controls
- Strategic decision-making
- Cross-functional team leadership
- Biotechnology and pharmaceutical industry knowledge
Professional Impact
Under Mark's leadership, Mozart Therapeutics has achieved significant financial milestones, including securing multiple rounds of funding, implementing cost-saving initiatives, and streamlining the company's financial operations. His expertise in financial management and strategic planning has been instrumental in supporting the company's clinical development and commercialization efforts, positioning Mozart Therapeutics for long-term success.
Conclusion
With his extensive experience in the biotechnology and pharmaceutical industries, Mark Steffen is a seasoned finance and administration executive who has demonstrated a proven track record of driving financial and operational excellence. In his current role at Mozart Therapeutics, he continues to contribute to the company's growth and strategic direction, leveraging his strong financial acumen and industry expertise to create value for the organization and its stakeholders.